SCHEMBL8692245

SCHEMBL8692245

C=CCOc1ccc2cccc(CCCC(=O)NC)c2c1

nearest known ligand 0.67

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 19/20 0.67
MTNR1B P49286 11/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8021299 0.86 MTNR1A (0.68) MTNR1AMTNR1B
SCHEMBL7024281 0.85 MTNR1A (0.83) MTNR1AMTNR1B
SCHEMBL8690256 0.84 MTNR1A (0.67) MTNR1AMTNR1B
SCHEMBL6247364 0.84 MTNR1A (0.86) MTNR1AMTNR1B
SCHEMBL7837695 0.80 MTNR1A (0.80) MTNR1AMTNR1B
SCHEMBL8690625 0.78 MTNR1A (0.66) MTNR1AMTNR1B
SCHEMBL7019147 0.78 MTNR1A (0.60) MTNR1AMTNR1B
SCHEMBL7100944 0.77 MTNR1A (0.69) MTNR1AMTNR1B
SCHEMBL8017020 0.77 MTNR1A (1.00) MTNR1AMTNR1B
SCHEMBL7015703 0.73 MTNR1A (1.00) MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5721276-A TREATING DISORDERS OF MELATONINERGIC SYSTEM ADIR ET COMPAGNIE (FR) 1998-02-24 US claimed
CN-1059433-C New arylalkyl (thio) carboxamides, processes for preparing them and pharmacetuical compositions containing them ADIR (FR) 2000-12-13 CN disclosed
US-5721276-A TREATING DISORDERS OF MELATONINERGIC SYSTEM ADIR ET COMPAGNIE (FR) 1998-02-24 US disclosed
CN-1145894-A New arylalkyl (thio) carboxamides, processes for preparing them and pharmacetuical compositions containing them ADIR (FR) 1997-03-26 CN disclosed
EP-0745584-A1 Arylalkyl(thio) carboxamides compounds with affinity for melatonine receptors, processes for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1996-12-04 EP disclosed